Fig. 4From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort studyKaplan-Meier curves of survival during the 1-year follow-up. VASP: vasodilator-stimulated phosphoproteinBack to article page